Search Results 1231-1240 of 18413 for Immunode

1. Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma - Mayo Clinic

   Human immunodeficiency virus (HIV) infected patients are eligible provided they meet all other eligibility criteria, and: There is no prior history of ...

2. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Known infection with the human immunodeficiency virus (HIV/acquired immune deficiency syndrome [AIDS]) and/or patients taking highly active antiretroviral ...

3. Lenalidomide or Observation in Treating Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Human immunodeficiency virus (HIV) infection is not excluded; HIV+ patients must meet the following criteria: Cluster of differentiation (CD)4 cell count ...

4. Evening primrose - Mayo Clinic

   This medicine treats the infection caused by human immunodeficiency virus, also called HIV. Evening primrose oil might slow how quickly the body breaks down ...

5. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

   Positive serology and/or nucleic acid testing (NAT) for human immunodeficiency virus (HIV). Serology and/or NAT indicating active hepatitis B virus (HBV) ...

6. Study to Evaluate the Effectiveness and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy - Mayo Clinic

   Patients with acute or chronic infectious disease including hepatitis, tuberculosis, human immunodeficiency virus (HIV), and chronic urinary tract infections.

7. Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   Has known human immunodeficiency virus (HIV) and CD4 count < 350 cells/μL and/or a history of an AIDS-defining opportunistic infection within the past 12 months ...

8. A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis - Mayo Clinic

   * Bronchiectasis due to cystic fibrosis, hypogammaglobulinemia common variable immunodeficiency, severe immunodeficiency, or requirement for treatment with ...

9. A Study to Evaluate a New Anti-Cancer Vaccine for Patients with Non-Small Cell Lung Cancer, Given After Tumor Removal by Surgery - Mayo Clinic

   Known to be Human Immunodeficiency Virus (HIV) -positive; Has an uncontrolled bleeding disorder; Has uncontrolled congestive heart failure or uncontrolled ...

10. A Study to Assess Clonal Diversity of Freshly Taken ESD Specimens - Mayo Clinic

    Inclusion Criteria: Patients with Barrett's Esophagus (BE) or Esophageal Adenocarcinoma (EAC) that are planned for Endoscopic Submucosal Dissection (ESD) ...